[{"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0672-2020", "product_description": "BAC 4000MCG /FENT 600MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@16 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077653"], "brand_name": ["VENLAFAXINE"], "generic_name": ["VENLAFAXINE"], "manufacturer_name": ["Bryant Ranch Prepack"], "product_ndc": ["63629-3324"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["313586"], "spl_id": ["8835dd5f-f15f-46e0-bc19-079933018cd2"], "spl_set_id": ["185d90ab-1ba4-dd59-0565-e35f0fd39a2d"], "package_ndc": ["63629-3324-1", "63629-3324-2", "63629-3324-3", "63629-3324-4", "63629-3324-5", "63629-3324-6", "36290-3324-2"], "original_packager_product_ndc": ["68382-021"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "73683", "recalling_firm": "Bryant Ranch Prepack Inc.", "address_1": "1919 N Victory Pl", "address_2": "", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0837-2016", "product_description": "Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b) 100-count bottle (NDC 63629-3324-6), Rx Only,  Manufactured by Teva Pharmaceuticals USA, Inc. Packaged by Bryant Ranch.", "product_quantity": "21 bottles (910 extended release tablets)", "reason_for_recall": "Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.", "recall_initiation_date": "20160325", "center_classification_date": "20160504", "termination_date": "20160829", "report_date": "20160511", "code_info": "Lot # 94983; Exp 10/17", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg may have potentially been mislabeled as one of the following drugs:  CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: W003460, EXP: 6/20/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD60240_1, EXP: 5/22/2014.", "address_2": "", "product_quantity": "720 Tablets", "code_info": "CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg has the following codes:   Pedigree: W003461, EXP: 6/20/2014;  Pedigree: AD60428_1, EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536342408.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-929-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0984-2020", "product_description": "Testosterone Cypionate Injection, TESTOSTERONE CYP IN GRAPESEED OIL [1ML] 200 MG/ML INJECTABLE, For IM Use, 1 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 03062019+51706, Exp 6/28/2020"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["BENZOYL PEROXIDE"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-101"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["308689"], "spl_id": ["eae4cff7-3c1c-429e-85ec-ba5f2075562b"], "spl_set_id": ["0ba5e88c-a4d5-4550-93fa-d3d7fee45f9f"], "package_ndc": ["45802-101-96"], "is_original_packager": [true], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0542-2021", "product_description": "Benzoyl Peroxide 2.5% Aqueous Base, Acne Treatment Gel Net Wt. 2.1 oz (60 g) NDC 45802-101-96 Distributed By Perrigo Allegan, MI 49010", "product_quantity": "5 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "one vial", "code_info": "Lot#: 20171017@85, BUD: 04/15/2018", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Pregnenolone 100 mg (SD) pellet, amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0649-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-949-2013", "product_description": "DEXTROSE PF 50% INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "05202013@11, 07092013@19", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0804-2022", "product_description": "T-106, Papaverine 30 mg/mL . Phentolamine 1 mg/mL . Alprostadil 25 mcg/mL, Packaged as  a) 10 mL Multi-Dose vial, NDC: 73198-0013-10; b) 5 mL Multi-Dose vial, NDC 73198-0013-05; Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835.", "product_quantity": "4129 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: a) E24510 BUD: 5/10/2022, E24610 BUD: 5/10/2022; b) H42H03 BUD: 8/3/2022, E24810 BUD: 5/10/2022, H42203 BUD: 8/3/2022", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:    0392297      0392297    0395407", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MEPIVACAINE HCL/EPINEPHRINE. 2%/1:100,000 (0.001%) INJECTABLE\t30 ML  \t  \t60 ML;  MEPIVICAINE HCL 3% (30MG/ML) INJECTABLE\t6 MLS  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1570-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "70635", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0402-2015", "product_description": "Quinapril Tablets USP, 40 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN  38478, UPC 5026869115, NDC 50268-691-15", "product_quantity": "431 unit dose packs", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20150227", "center_classification_date": "20150304", "termination_date": "20150922", "report_date": "20150311", "code_info": "Lot number:  I1407932, Exp. 02/2016"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-454-2013", "product_description": "Bimix Inj 30:0.5 MDV, 5 ml syr  Penile Injection, 90 day expiration,", "product_quantity": "5", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0983-2020", "product_description": "Testosterone Cypionate Injection,TESTOSTERONE CYP IN GRAPESEED OIL [10ML] 200 MG/ML INJECTABLE, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 03252019+51850, Exp 7/6/2020; 04252019+52098, Exp 6/29/2020; 04292019+52108, Exp 6/29/2020; 05012019+52132, Exp 10/22/2020; 05202019+52268, Exp 11/10/2020; 05222019+52290, Exp 11/10/2020; 05302019+52334, Exp 11/20/2020; 07082019+52594, Exp 12/29/2020; 07102019+52619, Exp 12/29/2020; 07292019+52762, Exp 8/12/2020; 07312019+52778, Exp 8/12/2020; 09102019+52898, Exp 1/16/2021; 09112019+52905, Exp 1/18/2021"}, {"status": "Terminated", "city": "Brewerton", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61256", "recalling_firm": "www.vitaminbestbuy.com", "address_1": "6001 McKinley Rd.", "address_2": "N/A", "postal_code": "13029", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1698-2012", "product_description": "Hard Ten Days Capsule, 4500 mg, boxes of 6 packets, OTC, Developed by:  American Federal International Living Creature Group and Tibet Gold Source Living Creature Engineering Limited Company, Unit 18, 55 Beijing Road Central, Lhasa, Tibet", "product_quantity": "550 boxes", "reason_for_recall": "Marketed Without an Approved ANDA/NDA:  presence of sildenafil", "recall_initiation_date": "20120223", "center_classification_date": "20120926", "termination_date": "20181101", "report_date": "20121003", "code_info": "All lots.", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75565", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0171-2017", "product_description": "Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.", "product_quantity": "N/A", "reason_for_recall": "Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.", "recall_initiation_date": "20161101", "center_classification_date": "20161208", "termination_date": "20180206", "report_date": "20161214", "code_info": "Lot #: 150335, 150336, Exp. 4/2017"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0999-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with CALCIUM, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0405-1", "product_quantity": "84 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251696, Exp. 7/15/2023."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "10 ml", "code_info": "All lots distributed between November 2014 and May 2015;  01272015@29, 7/26/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix ST4 (3 mg/1.5 mg/300 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1796-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021016"], "brand_name": ["RELPAX"], "generic_name": ["ELETRIPTAN HYDROBROMIDE"], "manufacturer_name": ["ROERIG"], "product_ndc": ["0049-2330", "0049-2340"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ELETRIPTAN HYDROBROMIDE"], "rxcui": ["359493", "359494", "404443", "404444"], "spl_id": ["a885a228-0468-4dea-9242-f59e8918cefa"], "spl_set_id": ["85745375-fcb6-4edc-b6db-a77b4a5f3e8c"], "package_ndc": ["0049-2330-79", "0049-2330-45", "0049-2340-79", "0049-2340-45", "0049-2340-05"], "is_original_packager": [true], "unii": ["M41W832TA3"]}, "product_type": "Drugs", "event_id": "83533", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-1845-2019", "product_description": "RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-45; b) 12-count (2 cards x 6 tablets) per carton, NDC 0049-2340-05, Rx only, Made in Ireland, Distributed by Pfizer Roerig, Division of Pfizer Inc., NY, NY  10017.", "product_quantity": "a) 20,117 cartons; b) 2,502 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.", "recall_initiation_date": "20190814", "center_classification_date": "20190828", "termination_date": "20230620", "report_date": "20190904", "code_info": "Lot #: a) AR5407, Exp 2022 FEB; b) CD4565, Exp 2022 FEB"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1161-2019", "product_description": "Methionine 15mg/Choline 100mg/ Inositol 50mg/ Methylcobalamin 1mg/ Lidocoaine 10 mg, benzyl alcohol/ water, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "276 vails", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090355"], "brand_name": ["THEOPHYLLINE"], "generic_name": ["THEOPHYLLINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-356", "68462-380"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["THEOPHYLLINE ANHYDROUS"], "rxcui": ["313291", "348472"], "spl_id": ["aaa6684e-4eef-42a8-92b6-8f317e570903"], "spl_set_id": ["56fc2167-ceb6-4e3e-8ff7-5e400dfbd533"], "package_ndc": ["68462-380-01", "68462-380-05", "68462-356-01", "68462-356-05"], "is_original_packager": [true], "upc": ["0368462380017", "0368462356012"], "nui": ["N0000175790", "M0023046"], "pharm_class_epc": ["Methylxanthine [EPC]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["0I55128JYK"]}, "product_type": "Drugs", "event_id": "97406", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0583-2025", "product_description": "Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa- 403513 India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ, NDC 68462-380-01", "product_quantity": "22,656 bottles", "reason_for_recall": "Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.", "recall_initiation_date": "20250808", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Batch # 19243193, 19243215, 19243231,19243248, 19243283, Exp 7/31/2026; 19244530, 19244561, Exp 10/31/2026; 19250178, Exp 12/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0102-2015", "product_description": "Methylcobalamin (PF) 25 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 04092014@14, Exp 10/6/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0804-2019", "product_description": "Dr. King's SafeCare Rx Indigestion Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955002420, NDC 57955-0024-2", "product_quantity": "194 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 041416M Exp. 04/19"}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1106-2017", "product_description": "Make Up Perfect ivory (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03300, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 033002.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 310318, Exp 03/31/2018."}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0099-2019", "product_description": "Metformin Hydrochloride Extended Release Tablets, 500 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories, FL Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 00591-2411-01", "product_quantity": "3,397 bottles", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Lot #: 1210888A, Exp 03/2019"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-422-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "195,699 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64934, Exp. 4/13; 65059, Exp. 5/13; 65179, Exp. 4/13; 65630, Exp. 7/13; 65916, Exp. 8/13; 66367, Exp. 10/13; and 66718, Exp. 11/13; b) 64338, Exp. 4/13; 64932, Exp. 4/13; 65060, Exp. 5/13; 65235, Exp. 6/13; 65853, Exp. 6/13; and 65962, Exp. 7/13"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0952-2023", "product_description": "glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1", "product_quantity": "770 Syringes", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-247022, Exp 08/07/2023; 36-239877, Exp 07/13/2023; 36-241448, Exp 07/20/2023; 36-251782, Exp 08/29/2023"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065095"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["62584-693"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["1d7291e1-b616-d4f6-e063-6394a90ab01a"], "spl_set_id": ["10988250-b267-4f10-b264-5f127cc1ae18"], "package_ndc": ["62584-693-11", "62584-693-21"], "original_packager_product_ndc": ["0143-2112"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "83466", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1582-2019", "product_description": "Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10 Unit Dose Blisters), Rx Only, Distributed by:  American Health Packaging, Columbus, Ohio, 43217, NDC Carton: 62584-693-21; NDC Unit Dose: 62584-693-11", "product_quantity": "6,579 cartons", "reason_for_recall": "Failed Dissolution Specifications: Out of specification result for the dissolution test.", "recall_initiation_date": "20180801", "center_classification_date": "20190731", "termination_date": "20200930", "report_date": "20190807", "code_info": "Lot 172569, Exp 7/31/2019"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0398-2022", "product_description": "Cefuroxime, Sterile Ophthalmic Solution for Injection, Preservative Free, 3mg/0.3mL (10 mg/mL), 0.3 mL single use syringe for Intraocular Injection, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446  NDC 05446-1003-01", "product_quantity": "1720 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "08-2021-30@1 12/20/2021, 09-2021-21@5 01/03/2022 & 10-2021-18@5 02/07/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["HYDROCORTISONE CREAM INTENSIVE HEALING"], "generic_name": ["HYDROCORTISONE CREAM"], "manufacturer_name": ["Walgreens"], "product_ndc": ["0363-0237"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["106258"], "spl_id": ["39db5fe1-a74d-f3f9-e063-6394a90a7f13"], "spl_set_id": ["8a3f486c-1353-466d-9ea7-c14559b53bf3"], "package_ndc": ["0363-0237-02", "0363-0237-03"], "is_original_packager": [true], "upc": ["0311917187297"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"]}, "product_type": "Drugs", "event_id": "81784", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0426-2019", "product_description": "Hydrocortisone Cream 1% MS Anti itch Cream with Intensive Healing 2 oz tubes, Distributed by: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015, NDC 0363-0237-03", "product_quantity": "67848 units", "reason_for_recall": "GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample", "recall_initiation_date": "20181207", "center_classification_date": "20190204", "termination_date": "20231106", "report_date": "20190213", "code_info": "Lot #: 36G17, 47G17, Exp. 5/2019; 84J17, Exp. 7/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-078-2013", "product_description": "Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "3,813,645 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HC31411 and  #HE18711"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075520"], "brand_name": ["NORTRIPTYLINE HYDROCHLORIDE"], "generic_name": ["NORTRIPTYLINE HYDROCHLORIDE"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "product_ndc": ["51672-4001", "51672-4002", "51672-4003", "51672-4004"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NORTRIPTYLINE HYDROCHLORIDE"], "rxcui": ["198045", "198046", "198047", "317136"], "spl_id": ["7ff22c22-51b5-4ce3-93ee-8959359fab3c"], "spl_set_id": ["aee2c1a1-d848-4c3b-8c6d-8a4f6ce94c28"], "package_ndc": ["51672-4001-6", "51672-4001-5", "51672-4001-1", "51672-4001-2", "51672-4002-6", "51672-4002-4", "51672-4002-5", "51672-4002-1", "51672-4002-2", "51672-4003-6", "51672-4003-5", "51672-4003-1", "51672-4003-2", "51672-4004-6", "51672-4004-5", "51672-4004-1", "51672-4004-2"], "is_original_packager": [true], "upc": ["0351672400118", "0351672400316", "0351672400415"], "unii": ["00FN6IH15D"]}, "product_type": "Drugs", "event_id": "87152", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0246-2021", "product_description": "Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1", "product_quantity": "44,256 bottles", "reason_for_recall": "CGMP deviations.", "recall_initiation_date": "20210108", "center_classification_date": "20210201", "termination_date": "20230907", "report_date": "20210210", "code_info": "AC05096, AC05098, and AC05099; Exp 10/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203582"], "brand_name": ["MONTELUKAST SODIUM"], "generic_name": ["MONTELUKAST SODIUM"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-110", "33342-111"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MONTELUKAST"], "rxcui": ["242438", "311759"], "spl_id": ["a12af8c6-41af-4850-b725-4f8226b35b67"], "spl_set_id": ["ce512844-5220-4661-809f-56d088699c9c"], "package_ndc": ["33342-110-07", "33342-110-10", "33342-110-15", "33342-110-12", "33342-110-39", "33342-110-44", "33342-111-07", "33342-111-10", "33342-111-15", "33342-111-12", "33342-111-39", "33342-111-44"], "is_original_packager": [true], "upc": ["0333342110077", "0333342111074"], "nui": ["N0000175777", "N0000000083"], "pharm_class_epc": ["Leukotriene Receptor Antagonist [EPC]"], "pharm_class_moa": ["Leukotriene Receptor Antagonists [MoA]"], "unii": ["MHM278SD3E"]}, "product_type": "Drugs", "event_id": "84749", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0823-2020", "product_description": "Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India  NDC 33342-111-10", "product_quantity": "10680 units", "reason_for_recall": "Failed Dissolution Specifications:  testing revealed low out of specification result in one lot of product", "recall_initiation_date": "20200120", "center_classification_date": "20200131", "termination_date": "20210426", "report_date": "20200205", "code_info": "Lot #: BMD8901B, Exp. Date 02/2021"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0553-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Menopause Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955500629, NDC 57955-6006-2", "product_quantity": "4119 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 033016J Exp. 03/19; 052516T Exp. 05/19; 080916D Exp. 08/2019; 090915B Exp. 09/18; 110117F Exp. 11/19"}, {"status": "Terminated", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021908"], "brand_name": ["AMITIZA"], "generic_name": ["LUBIPROSTONE"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "product_ndc": ["64764-080", "64764-240"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LUBIPROSTONE"], "rxcui": ["616578", "617768", "794639", "794641"], "spl_id": ["c2ca8178-4da1-42d1-a8b9-ff66dca82649"], "spl_set_id": ["d474ac6a-444d-4aa6-9986-24be6fcf811d"], "package_ndc": ["64764-080-60", "64764-080-40", "64764-240-60", "64764-240-10", "64764-240-40"], "is_original_packager": [true], "nui": ["N0000175573", "N0000175456"], "pharm_class_epc": ["Chloride Channel Activator [EPC]"], "pharm_class_moa": ["Chloride Channel Activators [MoA]"], "unii": ["7662KG2R6K"]}, "product_type": "Drugs", "event_id": "82830", "recalling_firm": "MALLINCKRODT PHARMACEUTICALS", "address_1": "1425 Us Highway 206", "address_2": "N/A", "postal_code": "07921-2653", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-1294-2019", "product_description": "Amitiza (lubiprostone) capsules, 8 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 64764-080-60", "product_quantity": "89,808 bottles", "reason_for_recall": "Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.", "recall_initiation_date": "20190513", "center_classification_date": "20190523", "termination_date": "20230717", "report_date": "20190529", "code_info": "Lot #: 3229691-61, Exp 01/2022"}, {"status": "Terminated", "city": "Qinhuangdao", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76890", "recalling_firm": "Qinhuangdao Zizhu Pharmaceutical, Co.", "address_1": "No 10, Longhai Road", "address_2": "Economic &amp; Technological Development Zon", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to NY, TX, SC, CO, MN and NJ", "recall_number": "D-0655-2017", "product_description": "Estradiol Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations; lack of quality assurance.", "recall_initiation_date": "20170324", "center_classification_date": "20170411", "termination_date": "20180703", "report_date": "20170419", "code_info": "Batch 80701510001 to  Batch 80001607002, exp 10/22/2017 through 7/5/2018", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0962-2022", "product_description": "Lidocaine HCl Injection, USP, 2%, 100 mg/5 mL (20 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-FIlled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-949-05", "product_quantity": "65590 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lot: LI2001A, Exp. 6/8/2022"}, {"country": "United States", "city": "Morgantown", "address_1": "781 Chestnut Ridge Rd", "reason_for_recall": "cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedure", "address_2": "", "product_quantity": "25,488 bottles", "code_info": "Lot Numbers# 3083005, 3083006, 3086121, and 3086122, exp Jan 2019", "center_classification_date": "20180517", "distribution_pattern": "Product was distributed throughout United States", "state": "WV", "product_description": "Amlodipine and Benazapril HCL Capsules, USP, 5 mg/10 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6896-01", "report_date": "20180523", "classification": "Class II", "openfda": {}, "recalling_firm": "Mylan Pharmaceuticals Inc.", "recall_number": "D-0819-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79957", "termination_date": "20190620", "more_code_info": "", "recall_initiation_date": "20180424", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0458-2017", "product_description": "Hydrocodone Bitartrate and Acetaminophen Oral Solution,  7.5 mg/325 mg per 15 mL C-II, a) 4 fl.oz .(120 mL), 12 bottles per case (NDC 66689-023-04), b) 16 fl.oz. (473 mL), 12 bottles per case (NDC 66689-023-16), c) 50 unit dose cups of 15 mL per case, (NDC No. 66689-023-50), Rx only, Manufactured by VistaPharm, Largo, FL 33771", "product_quantity": "32,027 bottles and 16,310 unit dose cups", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "a). Lot No. 419000 (Exp. 03/17)  b.) Lot No. 419800 (Exp. 03/17), 429100 (Exp. 06/17)  c). Lot No.  418200 (Exp. 03/17), 430100 (Exp. 06/17), 423800 (Exp. 04/17), 413100 (Exp. 02/17), 410700 (Exp. 01/17)", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0197-2018", "product_description": "Sincalide 5 mcg Lyophilized Vials, For IV Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "898 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 07052017@2 BUD: 1/1/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82969", "recalling_firm": "Synthetopes Inc", "address_1": "216 Earnhardt St", "address_2": "N/A", "postal_code": "29526-8287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1402-2019", "product_description": "Sulfur Colloid Reaction Vial 1.0 mL, Thaw Before Use, Not for Direct Injection, Store Frozen, Synthetopes, Inc.", "product_quantity": "20 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20190528", "center_classification_date": "20190620", "termination_date": "20201015", "report_date": "20190619", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68532", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "37497 Schoolcraft Rd", "address_2": "N/A", "postal_code": "48150-1007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan and Wisconsin", "recall_number": "D-1561-2014", "product_description": "adenosine 90 mg in 0.9% sodium chloride/90 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150", "product_quantity": "5 doses", "reason_for_recall": "Non Sterility; microbial contamination identified as Aspergillus species", "recall_initiation_date": "20140528", "center_classification_date": "20140825", "termination_date": "20140919", "report_date": "20140903", "code_info": "Lot# 13-920757-0-1 through Lot# 13-920757-0-5 (5 total doses)  EXP 06 JUL 2014"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0145-2023", "product_description": "Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment, USP, Net Wt. 3.5 g (1/8 oz.),  Rx Only, Manufactured by:  Akorn, INC., Lake Forest, IL 60045.  NDC:  17478-235-35", "product_quantity": "2,082 tubes", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: Lot 1K64A, EXP 9/30/2023"}, {"status": "Ongoing", "city": "Fenton", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92395", "recalling_firm": "SSM Health Care St. Louis DBA SSM St. Clare Health Center", "address_1": "1015 Bowles Ave", "address_2": "N/A", "postal_code": "63026-2394", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed in Missouri.", "recall_number": "D-0776-2023", "product_description": "HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394.  NDC: 60652-0600-2", "product_quantity": "3,232 syringes", "reason_for_recall": "CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.", "recall_initiation_date": "20230509", "center_classification_date": "20230531", "report_date": "20230607", "code_info": "Lot #: 20230222-45AB24, BUD: 8/21/2023; Lot #: 20230110-058361, BUD: 7/9/2023; Lot #: 20221208-0F5483, BUD: 6/6/2023; Lot #: 20221109-45BA60, BUD: 5/8/2023; Lot #:20220929-523FD5,  BUD: 3/28/2023; Lot#: 20220914-5D5AE0, BUD: 3/13/2023; Lot #: 220502-024, BUD: 10/29/2022; Lot #: 220510-035,  BUD: 11/6/2022; Lot #: 220526-015, BUD: 11/22/2022; Lot#: 220811-010, BUD: 2/7/2023"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0327-2017", "product_description": "Testosterone Cypionate in Grapeseed Oil Injectable, 200 mg/mL, a) 1 mL b) 3 mL c) 5 mL and d) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 694 vials b) 389 vials c) 695 vials d) 5193 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot codes: 03282016@16, 03302016@4, 04042016@10, 04262016@3, 05162016@2, 06032016@2, 07062016@10, 08262016@2    b) Known lot code: 04012016@4, 04182016@6, 04282016@7, 05022016@4, 06142016@19, 08102016@22.    c) Known lot code: 04042016@7, 05022016@9, 05272016@2, 06272016@13, 07292016@8, 08192016@10    d) Known lot code: 03242016@12, 04082016@6, 04142016@2, 04192016@5, 04272016@4, 05092016@4, 05232016@17, 06122016@6, 06082016@2, 06142016@148, 06162016@9, 06172016@13, 06232016@78, 06282016@31, 07122016@20, 08012016@25, 08032016@12, 08042016@13."}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0257-2016", "product_description": "Hyaluronic Acid/Lidocaine (20 mg/1%/2 mL), 3 mL Single Use Syringe, For Intra-Articular Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3239-01", "product_quantity": "105 syringes", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20151806@30 BUD: 11/7/2015, 20152306@38 BUD: 11/7/2015, 20151806@29 BUD: 11/7/2015, 20151903@30 BUD: 9/15/2015"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NASAL"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["Rite Aid Corporation"], "product_ndc": ["11822-6319"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["5c809981-45d4-4ab5-a803-34da80473901"], "spl_set_id": ["6c949602-e0c8-40ce-8fb3-5147f406fa04"], "package_ndc": ["11822-6319-1"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0621-2022", "product_description": "Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle,  DISTRIBUTED BY: RITE AID, 30 HUNTER LANE, CAMP HILL, PA 17011. NDC 11822-6319-1", "product_quantity": "15,264 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0964, Exp 01/31/2023; 1FK1164, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1363-2019", "product_description": "Guaifenesin AC Cough Syrup (Guaifenesin and Codeine Phosphate Oral Solution, USP) 100 mg/10 mg per 5 mL, One Pint (473 mL) bottle, NDC: 16571-302-16, Distributed by Rising Pharmaceuticals Inc., Saddle Brook, NJ 07663", "product_quantity": "233,388 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17H002; 17H005; 17H006; 17H007; 17H026; 17H027, Exp. 08/2019; 17J010; 17J013, Exp. 09/2019; 17K014; 17K015, Exp. 10/2019; 17L015, Exp. 11/2019; 17M026, Exp. 12/2019; 18A028; 18A031, Exp. 01/2020; 18B026, Exp. 02/2020; 18E003, Exp. 05/2020."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0261-2020", "product_description": "S-EDETATE DISODIUM 15% INJ, packaged in 50ml glass vial, Rx Only, Red Mountain Compounding RX.", "product_quantity": "10 50 ml vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:S07232019DH@14 Exp 8/23/19; S07162019DT@06 Exp 8/16/19; S07172019DT@04 Exp 8/17/19"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0467-2017", "product_description": "Methadone Hydrochloride Oral Concentrate, USP 5 mg/5 mL C-II, 500 mL, 6 bottles per case, Rx only, Manufactured by VistaPharm, Largo, FL 33771, NDC No. 66689-711-16.", "product_quantity": "3,354 bottles", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "Lot No. 388700 (Exp. 01/17)", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "448 units", "code_info": "Rx #'s:  0384355, 0389246, 0392332, 0399800, 0407377, 0385460, 0389158, 0402762, 0385460, 0359057, 0385462, 0396242, 0385462, 0391321, 0372399, 0400437, 388360, 0350745, 0354900, 0357950, 0365803, 0391686,  0393285, 0393620, 0395404, 0399228, 0399302, 0401675, 0401844, 0403731, 0406162, 0408427, 0409073, 0399228, 0371562, 0376422, 0396380, 0405576, 0405582, 0405586, 0384289, 0366702, 0360431, 0408278, 0390548, 0396007, 0401479, 0352078, 0352368, 0354526, 0354595, 0357480, 0358685, 0359207, 0363768, 0364549, 0368498, 0369212    0373766    0374428    0375279    0375571    0375873    0377397    0380000    0380005    0381659    0382914    0384657    0386665    0387419    0387519    0387699    0388026    0388292    0388330    0388766    0389900    0390082    0390315    0391607    0392449    0392525    0392848    0393087    0393381    0393499    0393828    0393904    0394395    0394985    0395878    0395912    0396010    0396019    0396120        0396163    0396207    0396267    0396366    0396906    0397063    0397523    0397527    0397728    0398291    0398862    0399237    0399251    0399644    0399898    0401001    0401380    0401414    0401480    0401858    0401991    0402382    0402634    0403182    0403417    0404396    0404958    0404962    0404965    0405377    0405697    0406246    0406753    0406809    0407466    0407512    0407521    0407830    0408706    0408768    0408828    0409007    0409150    0409158    0409809    0388728    0409113    0395179    0401812    0380005    0390728    0408848    0357188    0380005    0388326    0388531    0398590    0407315    0359319    0379979    0380005    0398376    0406549    0390081    0390728    0406512    0350594    0351237    0354526    0358579    0358794    0361059    0362431    0363752    0367108    0367355    0368710    0369213    0369806    0369811    0370264    0370618    0373793    0375571    0378322    0378326    0378513    0378942    0379218    0379983    0380003    0380005    0380149    0382749    0383556    0386269    0386665    0387095    0387179    0387861    0388633    0388634    0388636    0388637    0388638    0388641    0388894    0389374    0389385    0389548    0389790    0390777    0390779    0390781    0390782    0390784    0390790    0392100    0392378    0392380    0392388    0392390    0392508    0392649    0393106    0393111    0393112    0393114    0393115    0393117    0393118    0393836    0393838    0393839    0393841    0393843    0393846    0393848    0394141    0394181    0395615    0395620    0395622    0395623    0395625    0395628    0395632    0395635    0395636    0395921    0396045    0396534    0397327    0397406    0397473    0397475    0397476    0398304    0398372    0399460    0399467    0399469    0399471    0399476    0399478    0399481    0399841    0400028    0400032    0400169    0400782    0400791    0401362    0401477    0402466    0402681    0402687    0402699    0402709    0402711    0402713    0402715    0403292    0403743    0404300    0404953    0405053    0405058    0405061    0405264    0405284    0405391    0405392    0405394    0405850    0405855    0405863    0405866    0406896    0407031    0407430    0407614    0407619    0407623    0407625    0407626    0407631    0407708    0407758    0407835    0407845    0408266    0408719    0408839    0409260    0409369    0409644    0409663    0409666    0409667    0409672    0409676    0409685    0409803    0409810    0409811    0409984    0410385    0376121    0388330    0398376    0402184    0354526    0380005    0384306    0402150    0380005    0395412    0351617    0377040    0405279    0351625    0398027    0400613    0405073    0356174    0366355    0366652    0372365    0377239    0377604    0384197    0384239    0388883    0389914    0390003    0392798    0393394    0393804    0396191    0396863    0398155    0400682    0401354    0402361    0402772    0406281    0407525    0408139    0408807    0366728    0395638    0392966    0402974    0405261    0397156    0390549    0405381    0359548    0381259    0390539    0396023    0405381    0359548    0405381    0388337    0391331    0395269    0408053    0392770    0360349    0382004    0394651    0404245    0406333    0397786    0394838    0389554    0395413    0397465    0395413    0395411    0395411", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BIMIX   30MG / 4MG INJECTABLE 10 ML, 5 ML; BIMIX   30MG / 5MG INJECTABLE 10 ML; BIMIX   9MG / 0.25MG INJECTABLE 10 ML, 5 ML; BIMIX  15MG / 1MG INJECTABLE 10 ML; BIMIX  18MG / 0.5MG INJECTABLE 10 ML, 5 ML; BIMIX  18MG / 1MG INJECTABLE 5 ML; BIMIX  20MG / 0.75MG INJECTABLE 5 ML; BIMIX  26MG/1MG/ML INJECTABLE 10 ML; BIMIX  26MG/2MG/ML INJECTABLE 20 ML; BIMIX  30MG / 0.5MG INJECTABLE 10 ML, 20 ML,5 ML, 50 ML, 60 ML; BIMIX  30MG / 1.5MG INJECTABLE 5 ML; BIMIX  30MG/1MG INJECTABLE 1 ML, 10 ML, 10 MLS,\t12 ML, 150 ML, 2 ML, 20 ML, 20 MLS, 3 ML, 30 ML, 40 ML, 5 ML, 5 MLS, 50 ML, 6 ML, 60 ML, 7 ML; BIMIX  9MG / 0.5MG/ML INJECTABLE 5 ML; BIMIX 15MG / 0.5MG INJECTABLE 10 ML, 5 ML; BIMIX 16.6MG / 0.55MG/ML INJECTABLE 10 ML, 4.5 ML; BIMIX 30MG / 2MG INJECTABLE 10 ML, 5 ML; BIMIX 30MG/3MG/ML INJECTABLE 10 ML, 5 ML; BIMIX 40MG/2MG INJECTABLE 10 ML, 3 ML, 6 ML; BIMIX 40MG/3MG INJECTABLE 3 ML; BIMIX, SDSM  9MG / 0.25MG INJECTABLE 10 ML; BIMIX, SDSM  9MG / 0.5MG INJECTABLE 10 ML; BIMIX, SDSM 18MG / 0.5MG INJECTABLE 10 ML, 10 MLS; BIMIX, SDSM 30MG / 1.5MG INJECTABLE 10 ML, 10 MLS, 5 ML, 5 MLS; BIMIX, SDSM 30MG / 1MG INJECTABLE 10 ML, 5 ML (58 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1466-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Dyersburg", "address_1": "450 US Hwy 51 Byp N", "reason_for_recall": "Superpotent and Subpotent drugs", "address_2": "", "product_quantity": "353 pellets", "code_info": "Lot Number 08172016@9, BUD:  02/13/2017", "center_classification_date": "20161108", "distribution_pattern": "U.S.", "state": "TN", "product_description": "Estradiol 12.5 mg Pellet,  Compounded by: Wells Pharmacy Network", "report_date": "20161116", "classification": "Class III", "openfda": {}, "recalling_firm": "Wells Pharmacy Network, LLC", "recall_number": "D-0132-2017", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "75247", "termination_date": "20170329", "more_code_info": "", "recall_initiation_date": "20160919", "postal_code": "38024-3655", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-544-2013", "product_description": "Z-Dex Syrup, Decongestant, Antitussive, Expectorant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0002-16", "product_quantity": "2388 - 16 ounce bottles.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11EQ004  Exp 04/13."}, {"status": "Terminated", "city": "Northborough", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78286", "recalling_firm": "Genzyme Corporation", "address_1": "11 Forbes Rd", "address_2": "N/A", "postal_code": "01532-2501", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0075-2018", "product_description": "Clolar (clofarabine) 20 mg/20 mL (1 mg/mL)  Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5   Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.", "product_quantity": "9,343 single dose vials", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert.", "recall_initiation_date": "20171012", "center_classification_date": "20171110", "termination_date": "20200910", "report_date": "20171122", "code_info": "Lot #: K5006Y01; Exp. 08/31/18  Lot #: K5006Y03; Exp. 08/31/18    Lot #: K6001Y01; Exp. 03/31/19"}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90215", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide to the U.S. market", "recall_number": "D-0888-2022", "product_description": "Zonisamide Capsules USP, 100 mg, 90-count bottle,  Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90", "product_quantity": "16 bottles", "reason_for_recall": "CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.", "recall_initiation_date": "20220513", "center_classification_date": "20220520", "termination_date": "20240930", "report_date": "20220601", "code_info": "Lot: 23JY2124 Exp. 6/30/23", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0950-2020", "product_description": "Deoxycholic Acid Sodium Injection,DEOXYCHOLIC ACID SODIUM 1.67% INJECTABLE, For SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0462-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10082019+53080, Exp 6/30/2020; 11192019+53251, Exp  8/24/2020"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1439-2022", "product_description": "MIDOL COMPLETE CAPLET 16 CT SKU 913028   QP MENSTRUAL RELIEF COMPLETE CAPLET 16CT SKU 999982   QP PMS FORMULA CAPLET 32 CT SKU 913232 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 913028 ;  999982;  SKUs: 913232; 999982; 913028", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-043-2014", "product_description": "B-12 (Methyl) 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "7 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0735-2019", "product_description": "Dr. King's SafeCare Rx Allergies Animal Hair & Dander Allergy, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955219620, NDC 57955-2196-2", "product_quantity": "143 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 020117G Exp. 02/20"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0146-2022", "product_description": "TRIMTROPIC - MIC B COMPLEX/CHROM/CARN 20MG/40MG/50MG/5MG/33MG/2MG/1MG/25MCG/25MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08062021:92 BUD: 02/02/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-950-2013", "product_description": "DMSO 50% INJ 50 ML VIAL INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "07162013@16 and 02262013@9", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0667-2020", "product_description": "BAC 200MCG/ CLONI 250MCG/ MORP 10MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12102019@8 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92425", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "N/A", "initial_firm_notification": "N/A", "distribution_pattern": "USA nationwide", "recall_number": "D-0891-2023", "product_description": "Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01", "product_quantity": "12960 vials", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20230530", "center_classification_date": "20230629", "termination_date": "20231218", "report_date": "20230705", "code_info": "Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69405", "recalling_firm": "Avella of Deer Valley, Inc.", "address_1": "23620 N 20th Dr Ste 12", "address_2": "N/A", "postal_code": "85085-0621", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0016-2014", "product_description": "HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTABLE IM USE. Manufactured by Avella Specialty Pharmacy, Phoenix, AZ 85085.", "product_quantity": "197 vials", "reason_for_recall": "Crystallization: Formation of crystals observed in product.", "recall_initiation_date": "20141001", "center_classification_date": "20141010", "termination_date": "20150220", "report_date": "20141022", "code_info": "Lot#  12-20140207@109; Exp. 12/14    Lot#  12-20142107@82;   Exp.  01/15"}, {"status": "Ongoing", "city": "Bryan", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97053", "recalling_firm": "Nostrum Laboratories, Inc.", "address_1": "705 E Mulberry St", "address_2": "", "postal_code": "43506-1432", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide within the United States", "recall_number": "D-0547-2025", "product_description": "Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) 500-count bottles, NDC 29033-0003-05), Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120.", "product_quantity": "60,608 bottles", "reason_for_recall": "CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.", "recall_initiation_date": "20250711", "center_classification_date": "20250731", "report_date": "20250806", "code_info": "All Lots within expiry dates.", "more_code_info": ""}, {"status": "Terminated", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88008", "recalling_firm": "McKesson Corporation dba McKesson Drug Company", "address_1": "4853 Crumpler Rd", "address_2": "N/A", "postal_code": "38141-8301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0630-2021", "product_description": "Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141  Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India  NDC 63739-795-10", "product_quantity": "210 cartons", "reason_for_recall": "Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam", "recall_initiation_date": "20210526", "center_classification_date": "20210615", "termination_date": "20220929", "report_date": "20210616", "code_info": "Lot: 0000124916 Exp. 09/30/2022"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0328-2022", "product_description": "EQUALINE aller-ease fexofenadine hydrochloride tablets, 180 mg, 24 HR, packaged as a) 15 count bottle, NDC 41163-571-22, UPC 0 41163 48067 4; b) 70 tablets per bottle, NDC 41163-571-01, UPC 0 41163 49847 1; Made in the Czech Republic, Distributed by: UNFI Providence, RI 02908.", "product_quantity": "55,032  units", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot # a)0HE2530 Exp 12/31/2021, 0KE2980 EXP 02/28/2022 b)0FR0461 Exp 2/28/2022"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-666-2015", "product_description": "Etoposide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67412", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1092-2014", "product_description": "Teva Ethambutol Hydrochloride Tablets, USP, 400 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA., NDC 0555-0923-02.", "product_quantity": "10405 tablets", "reason_for_recall": "CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved material: the incorrect gelatin excipient than specified in the product formulation.", "recall_initiation_date": "20140124", "center_classification_date": "20140228", "termination_date": "20141008", "report_date": "20140312", "code_info": "Lot # 34013698A, Exp.  01/16.  Lot #  34013699A, Exp. 01/16.  Lot #  34013700A, Exp. 01/16.  Lot #  34013756A, Exp. 01/16.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["CAREONE ALLERGY RELIEF"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Retail Business Services, LLC"], "product_ndc": ["72476-847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["4679cef1-6a61-4814-9013-b631d7ced002"], "spl_set_id": ["ce398856-e9a6-401d-8636-bc5771a7e28b"], "package_ndc": ["72476-847-22", "72476-847-39", "72476-847-95"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0902-2023", "product_description": "Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 15-count cartons, Distributed By: Adusa Distribution, LLC, Salisbury, NC 28147.  NDC 72476-847-22", "product_quantity": "3,240 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: 2JE2185, Exp. date 01/24", "more_code_info": ""}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "Failed Impurities/Degradation Specifications:There is a potential for the tablets to be out of specification for impurities throughout shelf life.", "address_2": "", "product_quantity": "1,249,700 tablets", "code_info": "lot #14071112AA; Exp. 03/14.   lot #14071112AB;  Exp. 03/14.   lot # 14071012BA;  Exp. 03/14.  lot #14071012BB;  Exp 03/14.", "center_classification_date": "20140204", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Hydralazine HCL Tablets, USP, 25 mg in a single blister package, Manufactured in Czech Republic By: Teva Czech Industries s.r.o. Opava-Komarov, Czech Republic, Distributed by Goldline Laboratories, Sellersville, PA, NDC 00182-0554-89  (carton) and 00182-0554-00 (single blister).", "report_date": "20140212", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D-1074-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67141", "termination_date": "20141022", "more_code_info": "", "recall_initiation_date": "20131218", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Chestnut Ridge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85333", "recalling_firm": "Par Pharmaceutical Inc.", "address_1": "1 Ram Ridge Rd", "address_2": "N/A", "postal_code": "10977-6714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the United States.", "recall_number": "D-1071-2020", "product_description": "Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India   NDC# 49884-0065-01", "product_quantity": "29,352 bottles", "reason_for_recall": "Failed Impurities/Degradation Specification: Presence of unknown impurity observed.", "recall_initiation_date": "20200330", "center_classification_date": "20200330", "termination_date": "20211102", "report_date": "20200408", "code_info": "Lot # 32809101, Exp 3/2021"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "10", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Magnesium Sulfate 1GM Added to 0.9% Sodium Chloride,  50 mL bag, Rx only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0803-41", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1302-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Laurelton", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040275"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["EPIC PHARMA, LLC"], "product_ndc": ["42806-087", "42806-088", "42806-089"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["197657", "197658", "197659"], "spl_id": ["2b205859-076c-1703-e063-6394a90ac140"], "spl_set_id": ["9333d92f-2585-4b99-aaea-87c01c95125e"], "package_ndc": ["42806-087-01", "42806-087-05", "42806-088-01", "42806-088-05", "42806-089-09", "42806-089-01", "42806-089-05"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "81729", "recalling_firm": "Epic Pharma, LLC", "address_1": "22715 N Conduit Ave", "address_2": "", "postal_code": "11413-3134", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0297-2019", "product_description": "Estradiol Tablets, USP, 2 mg, 100-count bottle, Rx Only, Distributed by: Epic Pharma, LLC Laurelton, NY 11413, NDC 42806-089-01", "product_quantity": "2976 bottles", "reason_for_recall": "Presence of foreign tablet/capsule: A single foreign tablet was found in pharmacy dispensed bottle of 30 Estradiol 2 mg tablets.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "termination_date": "20210209", "report_date": "20181226", "code_info": "Lot #: 18103A, Exp 6/20", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076900"], "brand_name": ["ATENOLOL"], "generic_name": ["ATENOLOL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-022", "68382-023", "68382-024"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATENOLOL"], "rxcui": ["197379", "197380", "197381"], "spl_id": ["860eb406-b330-4b72-b768-122d57c74293"], "spl_set_id": ["db801706-1362-44c7-92ab-f584f96c7e1c"], "package_ndc": ["68382-022-16", "68382-022-01", "68382-022-10", "68382-022-40", "68382-022-24", "68382-023-16", "68382-023-01", "68382-023-10", "68382-023-02", "68382-023-40", "68382-023-24", "68382-024-16", "68382-024-01", "68382-024-10", "68382-024-40"], "is_original_packager": [true], "nui": ["N0000000161", "N0000175556"], "pharm_class_moa": ["Adrenergic beta-Antagonists [MoA]"], "pharm_class_epc": ["beta-Adrenergic Blocker [EPC]"], "unii": ["50VV3VW0TI"]}, "product_type": "Drugs", "event_id": "68988", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0007-2015", "product_description": "ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA  NDC 68382-022-01", "product_quantity": "5400 bottles", "reason_for_recall": "Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets  were noticeably thicker in appearance.", "recall_initiation_date": "20140805", "center_classification_date": "20141003", "termination_date": "20170922", "report_date": "20141015", "code_info": "MP2292 Exp. 01/16", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0115-2015", "product_description": "PGE 4, 300 mcg/mL injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "60 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08062014@40, Exp 11/4/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "70720", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0487-2015", "product_description": "Bromfenac Ophthalmic Solution 0.09%, Rx Only. Mfg For: Apotex Corp., Weston, FL, 33326.  Available in a) 1.7 mL Bottle, NDC: 60505-0595-5; b) 2 x 1.7 mL Bottles, NDC: 60505-0595-6; c) 2.5 mL Bottles, NDC: 60505-0596-4.", "product_quantity": "33,795 Bottles", "reason_for_recall": "CGMP Deviations: Product excipient was not re-tested at the appropriate date.", "recall_initiation_date": "20150212", "center_classification_date": "20150415", "termination_date": "20161230", "report_date": "20150422", "code_info": "a) Lot #: KY8498, Expiry: 01/2016; b) Lot #: KY8496, Expiry: 01/2016; c) Lot #: MC5426, Expiry: 02/2016; Lot #: KZ2002, Expiry: 04/2016."}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1456-2020", "product_description": "A Clean Choice CBD, Hemp Oil Extract Tincture, Sweet Mint, 500mg, 1 fl oz (30 ml) bottles, Made in Michigan for A Clean Choice, A Division of A Clean Cigarette, Inc., 3055 Bay Rd Suite 1, Saginaw, MI 48603", "product_quantity": "200 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003113", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0793-2023", "product_description": "Cimetidine HCl Oral Solution 300mg/5mL, 237 mL bottles, Rx Only, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0669-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-029-01", "product_quantity": "3,384 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250158A, Exp Date: 06-22-2027", "more_code_info": ""}, {"status": "Terminated", "city": "Bangalore", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA210733"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-860", "64380-861"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312529", "628953"], "spl_id": ["a74390de-64e9-482d-8630-d1a2452324fe"], "spl_set_id": ["0224e5b3-3c49-4e6e-aa78-1abcc6969246"], "package_ndc": ["64380-860-06", "64380-860-07", "64380-860-08", "64380-861-06", "64380-861-07", "64380-861-08"], "is_original_packager": [true], "upc": ["0364380861065", "0364380860068"], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "84968", "recalling_firm": "Strides Pharma Science Limited", "address_1": "Krs Gardens, No.36/7 Suragajakkanahalli", "address_2": "Indlawadi Cross, Anekal Taluk", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1029-2020", "product_description": "Potassium Chloride Extended-Release Tablets USP, 10mEq  (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08", "product_quantity": "2576 bottles", "reason_for_recall": "Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.", "recall_initiation_date": "20200217", "center_classification_date": "20200313", "termination_date": "20210216", "report_date": "20200325", "code_info": "Lot #: 7238958A, 7238257A, Exp  7/31/2021; 7239404A, Exp 9/30/2021", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0438-2020", "product_description": "ActivEyes Preservative Free Multi-Dose Lubricant Drops Sensitive PF Sterile, 0.25 FL OZ (7.5 mL), Manufactured by: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-146-52", "product_quantity": "47 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "18099 4/20"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0744-2021", "product_description": "Octreotide Acetate Injection 100 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3311-01", "product_quantity": "3,067 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31327466B, exp. date 08/2021"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203536"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-360", "59746-361", "59746-362", "59746-363"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["9c828bee-09d3-4021-99e7-e5fd3e83741c"], "spl_set_id": ["9402b022-5809-4251-dfef-54f6ef5723fe"], "package_ndc": ["59746-360-30", "59746-360-90", "59746-360-05", "59746-360-03", "59746-361-30", "59746-361-90", "59746-361-05", "59746-361-03", "59746-362-30", "59746-362-90", "59746-362-05", "59746-362-03", "59746-363-30", "59746-363-90", "59746-363-67", "59746-363-32"], "is_original_packager": [true], "upc": ["0359746363321", "0359746363307", "0359746361037", "0359746362034", "0359746360306", "0359746360030", "0359746361303", "0359746362300"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "80836", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States to wholesalers and retailers.", "recall_number": "D-1103-2018", "product_description": "Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30", "product_quantity": "10,577 bottles", "reason_for_recall": "Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.", "recall_initiation_date": "20180814", "center_classification_date": "20180817", "termination_date": "20200108", "report_date": "20180829", "code_info": "Lot #: VR117014A, VR117015A, Exp. 08/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Bedford", "state": "NH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72233", "recalling_firm": "Bedford Pharmacy", "address_1": "209 Route 101", "address_2": "N/A", "postal_code": "03110-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NH, MA", "recall_number": "D-0041-2016", "product_description": "P-P-P (COBAL) 30-1-20/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20150922", "center_classification_date": "20151015", "termination_date": "20160608", "report_date": "20151021", "code_info": "Lot #: 08132015@9, Exp 09/27/2015"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091436"], "brand_name": ["LEVOFLOXACIN"], "generic_name": ["LEVOFLOXACIN"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-045", "36000-046", "36000-047", "36000-048"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVOFLOXACIN"], "rxcui": ["1665497", "1665507", "1665515", "1665517"], "spl_id": ["3cbc7b81-fabf-4666-951c-76f19e4f3222"], "spl_set_id": ["70c87464-1806-480a-8ebd-3f02987ff436"], "package_ndc": ["36000-045-01", "36000-046-24", "36000-047-24", "36000-048-24"], "is_original_packager": [true], "upc": ["0336000047241", "0336000045018", "0336000046244"], "nui": ["N0000193223", "M0372253"], "pharm_class_epc": ["Fluoroquinolone Antibacterial [EPC]"], "pharm_class_cs": ["Fluoroquinolones [CS]"], "unii": ["6GNT3Y5LMF"]}, "product_type": "Drugs", "event_id": "80653", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1035-2018", "product_description": "Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24.", "product_quantity": "106,320 bags", "reason_for_recall": "Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.", "recall_initiation_date": "20180801", "center_classification_date": "20180803", "termination_date": "20200716", "report_date": "20180815", "code_info": "Lot#: A0A0954, A0A0958, A0A0970, Exp 09/19"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1010-2017", "product_description": "fentaNYL as citrate 5 mcg/mL in 0.9% Sodium Chloride 1 mL in Single Dose syringe, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0225-24", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lot: 20170510@40 BUD: 8/8/2017"}, {"status": "Terminated", "city": "Norwalk", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91719", "recalling_firm": "Ecometics, Inc.", "address_1": "19 Concord St", "address_2": "", "postal_code": "06854-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0447-2023", "product_description": "Vencedor medicated balm (capsaicin 0.028%) 1.5 oz. (43g) tubes, Distributed by: The Larkspur Group Inc. Norwalk, CT  06854", "product_quantity": "4,210 metal tubes/folding carton", "reason_for_recall": "CGMP DEVIATIONS", "recall_initiation_date": "20230224", "center_classification_date": "20230308", "termination_date": "20230621", "report_date": "20230315", "code_info": "Lot #: 2E021A, Exp. Date Jan-25", "more_code_info": ""}, {"status": "Terminated", "city": "Buffalo Grove", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211713"], "brand_name": ["MICAFUNGIN"], "generic_name": ["MICAFUNGIN SODIUM"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "product_ndc": ["70594-036", "70594-037"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["MICAFUNGIN SODIUM"], "rxcui": ["861379", "861383"], "spl_id": ["e26f3507-cb01-46d6-8fa4-c64588a71574"], "spl_set_id": ["3bc8668e-8ec3-4c54-b46b-5ca0dac87c1b"], "package_ndc": ["70594-037-01", "70594-036-01"], "is_original_packager": [true], "unii": ["IS1UP79R56"]}, "product_type": "Drugs", "event_id": "88457", "recalling_firm": "XELLIA PHARMACEUTICALS USA, LLC", "address_1": "2150 E Lake Cook Rd", "address_2": "N/A", "postal_code": "60089-1862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0757-2021", "product_description": "Micafungin for Injection, 100 mg/vial, Single-Dose Vial, Sterile, Rx Only, For Intravenous Infusion Only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089.  NDC 70594-037-01", "product_quantity": "9,161 (50mg and 100  mg vials total)", "reason_for_recall": "Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.", "recall_initiation_date": "20210806", "center_classification_date": "20210820", "termination_date": "20240929", "report_date": "20210901", "code_info": "Lot 467111, exp 1/2023"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2"], "spl_set_id": ["aa086a21-de85-4b03-af58-49b70acf8cf0"], "package_ndc": ["69238-1054-1", "69238-1056-1", "69238-1058-1", "69238-1060-1", "69238-1062-1"], "is_original_packager": [true], "upc": ["0369238105612", "0369238106213"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97438", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0617-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1058-1.", "product_quantity": "13,130 100-count bottles", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was   detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250818", "center_classification_date": "20250904", "report_date": "20250910", "code_info": "Lot: AM240147, AM240148, Exp Date 01/31/2027; Lot AM240664,  AM240665, Exp Date 04/30/2027."}, {"status": "Terminated", "city": "Roxboro", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86251", "recalling_firm": "Open Book Extracts", "address_1": "317 Lucy Garrett Rd", "address_2": "", "postal_code": "27574-9789", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1563-2020", "product_description": "Always Be Clean Hand Sanitizer (73% Alcohol) 0.04 FL OZ (1.2 mL) packaged in a) Single snaps (NDC 75091-2020-1 UPC 375091202016); b) 100-count boxes (NDC 75091-2020-2 UPC 375091202023); c) 25-count boxes (NDC 75091-2020-3 UPC 375091202030)", "product_quantity": "340,000 packs", "reason_for_recall": "Labeling Not Elsewhere Classified: Product labeled to contain methanol", "recall_initiation_date": "20200807", "center_classification_date": "20200909", "termination_date": "20220222", "report_date": "20200916", "code_info": "ES8-200514", "more_code_info": ""}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079031"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5346", "0093-5347", "0093-5348"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1806177", "1806179", "1806183"], "spl_id": ["663ba889-95b5-45c2-af06-c90459d30d6d"], "spl_set_id": ["034fb7cd-e183-475e-8beb-64fd88facc8f"], "package_ndc": ["0093-5346-01", "0093-5347-01", "0093-5348-01"], "is_original_packager": [true], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "65515", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-848-2013", "product_description": "Methylphenidate Hydrochloride Extended-Release Capsules (LA), 30 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5347-01", "product_quantity": "13,478 bottles", "reason_for_recall": "Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.", "recall_initiation_date": "20130618", "center_classification_date": "20130807", "termination_date": "20140827", "report_date": "20130814", "code_info": "34010290A, 34010291A, 34010292A, exp 04/14, 34011855A, 34011856A, 34011857A, 34011858A, 34013216A, 34013217A, 34013218A, exp 06/14."}, {"country": "United States", "city": "Nashville", "address_1": "110 20th Ave N", "reason_for_recall": "Presence of Particulate Matter", "address_2": "", "product_quantity": "3 vials", "code_info": "Lot #: 641:07, Expiry: 8/11/14", "center_classification_date": "20140425", "distribution_pattern": "MO, TN, MS, WI", "state": "TN", "product_description": "Polidocanol 3% Solution, 50 mL Vial, Rx Only, Not for Resale. John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.", "report_date": "20140507", "classification": "Class II", "openfda": {}, "recalling_firm": "John W Hollis Inc", "recall_number": "D-1260-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "67812", "termination_date": "20140501", "more_code_info": "", "recall_initiation_date": "20140317", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82827", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1452-2019", "product_description": "Pramipexole Dihydrochloride Tablets 1.5 mg 90-count bottle, Rx only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India   Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ NDC 68382-200-16", "product_quantity": "47,664 90-count bottles", "reason_for_recall": "CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.", "recall_initiation_date": "20190506", "center_classification_date": "20190701", "termination_date": "20210916", "report_date": "20190626", "code_info": "Lots: M713435 M713436 EXP Sep-19; M714191 EXP Oct-19; M808185 M808184 M808186 EXP May-20; M817634 M817635 EXP Nov-20"}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NINJACOF"], "generic_name": ["CHLOPHEDIANOL HCL AND PYRILAMINE MALEATE"], "manufacturer_name": ["Centurion Labs, LLC"], "product_ndc": ["23359-032"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CHLOPHEDIANOL HYDROCHLORIDE", "PYRILAMINE MALEATE"], "rxcui": ["1593749", "1593756"], "spl_id": ["2a306ef4-c68d-8904-e063-6294a90a32a0"], "spl_set_id": ["e2bca40f-9c27-ec8b-2ff0-ef9847ba2037"], "package_ndc": ["23359-032-16", "23359-032-10", "23359-032-04"], "is_original_packager": [true], "unii": ["69QQ58998Y", "R35D29L3ZA"]}, "product_type": "Drugs", "event_id": "74874", "recalling_firm": "Pharmatech LLC", "address_1": "4131 Sw 47th Ave", "address_2": "Suite 1403", "postal_code": "33314-4026", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1521-2016", "product_description": "Ninjacof (chlophedianol HCl and pyrilamine maleate) Liquid, 12.5 mg/12.5 mg in each 5 mL, 16 fl oz (473 mL) bottle, Manufactured for: Centurion Labs, LLC, Birmingham, AL  35243, NDC 23359-032-16.", "product_quantity": "5,928 bottles", "reason_for_recall": "CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.", "recall_initiation_date": "20160808", "center_classification_date": "20160927", "termination_date": "20240923", "report_date": "20161005", "code_info": "Lot #: 25291601, Exp 03/18"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA125084"], "brand_name": ["ERBITUX"], "generic_name": ["CETUXIMAB"], "manufacturer_name": ["ImClone LLC"], "product_ndc": ["66733-948", "66733-958"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CETUXIMAB"], "rxcui": ["1657658", "1657660", "1657663", "1657664"], "spl_id": ["f38a33cd-25c7-4d86-8f3c-e3168b6c2b48"], "spl_set_id": ["8bc6397e-4bd8-4d37-a007-a327e4da34d9"], "package_ndc": ["66733-948-23", "66733-958-23"], "is_original_packager": [true], "nui": ["N0000175664", "N0000020010"], "pharm_class_epc": ["Epidermal Growth Factor Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER1 Antagonists [MoA]"], "unii": ["PQX0D8J21J"]}, "product_type": "Drugs", "event_id": "81511", "recalling_firm": "Eli Lilly & Co", "address_1": "1 Lilly Corporate Ctr", "address_2": "", "postal_code": "46285-0001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, AZ, CA, KS, LA, MS, OH, OR, TN, TX and Puerto Rico", "recall_number": "D-0248-2019", "product_description": "ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by:  ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA.  NDC: 66733-958-23", "product_quantity": "9,380 vials", "reason_for_recall": "Labeling: Missing label; potential for missing primary container label on the vial.", "recall_initiation_date": "20181108", "center_classification_date": "20181115", "termination_date": "20200422", "report_date": "20181121", "code_info": "Lot number: C1700167, exp 9/2020", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "8 ml", "code_info": "All lots distributed between November 2014 and May 2015;    05082015@31, 11/4/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix  (30/1/20) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1779-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80128", "recalling_firm": "Shoreside Enterprises Inc.", "address_1": "6345 Newtown Cir Apt A3 Ste A-3", "address_2": "N/A", "postal_code": "33615-3629", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0879-2018", "product_description": "POSEIDON Xtreme PLATINUM 4500,1000mg, packaged in single packs sold in 24-count boxes, Distributed by: Poseidon Distribution Atlanta, GA, UPC 638632428857", "product_quantity": "Unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.", "recall_initiation_date": "20180517", "center_classification_date": "20180618", "termination_date": "20200610", "report_date": "20180606", "code_info": "Lot #: 201117BL, Exp. 01/2020"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0579-2020", "product_description": "Glutamine/Arginine/Carnitine in all strengths, all doses and all packaging, AnazaoHealth Corporate 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "17 vials", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled and dispensed 09/24-26/2019 remaining within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214331"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-306", "36000-372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["483017", "2715604"], "spl_id": ["8656ca5b-eba7-4812-b423-aab2ee0a16de"], "spl_set_id": ["0f67c1bd-915b-4681-88dd-22f5154a80b3"], "package_ndc": ["36000-306-60", "36000-372-40"], "is_original_packager": [true], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "97453", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0596-2025", "product_description": "Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60.", "product_quantity": "13,000 containers", "reason_for_recall": "Discoloration", "recall_initiation_date": "20250820", "center_classification_date": "20250822", "report_date": "20250903", "code_info": "Lot #: 24A27G66, Exp 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97370", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0577-2025", "product_description": "Carvedilol Tablets, USP, 3.125 mg, Packaged as: a)500-count bottle, NDC 68462-162-05; b) 100-count bottle, NDC 68462-162-01; Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India.  Manufactured for Glenmark Pharmaceuticals, Inc., Mahwah, NJ, USA, NJ 07430.", "product_quantity": "44,328 bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine,  N-Nitroso Carvedilol I  Impurity above the current Acceptable Intake Level.", "recall_initiation_date": "20250807", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Lot#: a)19242274, 19242275, 19242272, Exp: 5/31/20; b) 19242272, Exp: 5/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0811-2023", "product_description": "Hydromorphone Hydrochloride Injection, USP, 50mg/5mL (10 mg/mL) packaged in a) 1 mL ampules, b) 5 mL ampules, c) 50 mL vials, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}]